Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Zomedica Corp. Common Shares (NY: ZOM )

0.0973 UNCHANGED
Last Price Updated: 8:00 PM EST, Mar 4, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Zomedica Corp. Common Shares

< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Coinbase, Moderna And 56 Biggest Movers From Yesterday
Gainers Inspira Technologies Oxy B.H.N. Ltd. (NASDAQ: IINN) shares climbed 75.2% to close at $2.19 after the company announced it has developed a non-invasive blood sensor designated to alert real-time... 
Via Benzinga
Why Is SCWorx (WORX) Stock Up 37% Today?
SCWorx (WORX) stock is rocketing higher on Wednesday after boosting investor confidence with a stock purchase agreement! 
Via InvestorPlace
ZOM Stock Pops 5% as Zomedica Acquires Revo Squared
ZOM stock is on the rise as Zomedica acquires crucial technology that will provide veterinarians with enhanced diagnostic imaging quality. 
Via InvestorPlace
Dogs Win, Investors Lose With Zomedica
Zomedica still has cash from pushing its Truforma device last year, but the future of ZOM stock is based on PulseNet, bought in October. 
Via InvestorPlace
It’s Going to Take a Lot to Get Zomedica Stock Out of the Doghouse
ZOM stockholders are likely to grow increasingly frustrated with management's misplaced optimism and the lack of Truforma sales. 
Via InvestorPlace
Zomedica Finalizes Acquisition of Veterinary Imaging Company Revo Squared
ANN ARBOR, MI / ACCESSWIRE / July 6, 2022 / Zomedica Corp. (NYSE American:ZOM) ('Zomedica' or the 'Company'), a veterinary health company offering diagnostic and therapeutic products for companion... 
From Zomedica Corp.
Via AccessWire
Zomedica Announces Designation of PulseVet(R) System as the Official Shock Wave Therapy Supplier of the United States Equestrian Team
ANN ARBOR, MI / ACCESSWIRE / June 28, 2022 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or the "Company"), a veterinary health company offering diagnostic and therapeutic products for equine and... 
From Zomedica Corp.
Via AccessWire
Topics Supply Chain
Exposures Supply Chain
Zomedica to Participate in Panel Discussion at Animal Health Investment Forum
ANN ARBOR, MI / ACCESSWIRE / June 21, 2022 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or the "Company"), a veterinary health company offering diagnostic and therapeutic products for companion... 
From Zomedica Corp.
Via AccessWire
Zomedica to Acquire Assets of Innovative Veterinary Imaging Company Revo Squared
ANN ARBOR, MI / ACCESSWIRE / June 15, 2022 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or the "Company"), a veterinary health company offering diagnostic and therapeutic products for companion... 
From Zomedica Corp.
Via AccessWire
Zomedica to Investigate Shock Wave Therapy of Exercised Induced Pulmonary Hemorrhage in Horses
ANN ARBOR, MI / ACCESSWIRE / June 13, 2022 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or the "Company"), a veterinary health company offering diagnostic and therapeutic products for companion... 
From Zomedica Corp.
Via AccessWire
Topics Law Enforcement
Exposures Legal
Zomedica to Present at JMP Securities Life Sciences Conference
ANN ARBOR, MI / ACCESSWIRE / June 8, 2022 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or "Company"), a veterinary health company offering point-of-care diagnostics and therapeutic products for... 
From Zomedica Corp.
Via AccessWire
Karen DeHaan-Fullerton Joins Zomedica as General Counsel and Corporate Secretary
ANN ARBOR, MI / ACCESSWIRE / June 2, 2022 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or "Company"), a veterinary health company offering point-of-care diagnostics and therapeutic products for... 
From Zomedica Corp.
Via AccessWire
Zomedica Enters Into Strategic Investment and Potential Collaboration for VetGuardian Monitoring Product Line
ANN ARBOR, MI / ACCESSWIRE / May 19, 2022 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or the "Company"), a veterinary health company offering diagnostic and therapeutic products for companion... 
From Zomedica Corp.
Via AccessWire
Traders News Source Interviews Larry Heaton, CEO of Zomedica Corp.
NEW YORK, NY / ACCESSWIRE / May 18, 2022 / Traders News Source, a leading independent equity research and corporate access firm focused on small and mid cap publicly traded companies recently issued a... 
From Traders News Source
Via AccessWire
Zomedica CEO Interview with Wall Street Analyzer Discusses First Quarter 2022 Earnings and Future Plans
ANN ARBOR, MI / ACCESSWIRE / May 16, 2022 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or "Company"), a veterinary health company offering point-of-care diagnostics and therapeutic products for... 
From Zomedica Corp.
Via AccessWire
Why Zomedica Shares Are Falling Today
Zomedica Corp (NASDAQ: ZOM) shares are trading lower by 4.99% at $0.20. The company reported first-quarter earnings results during Tuesday’s after-hours session. Zomedica reported a first-quarter EPS... 
Via Benzinga
Zomedica Announces First Quarter 2022 Revenues of $3.8 Million; 74% Gross Margin & $192.3 Million in Cash; Revenue up 38% from 2021 Combined Revenues
ANN ARBOR, MI / ACCESSWIRE / May 10, 2022 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or "Company"), a veterinary health company offering point-of-care diagnostics and therapeutic products for... 
From Zomedica Corp.
Via AccessWire
Zomedica(R) Supports Feline Animal Health With American Association of Feline Practitioners' Sponsorship
Our newswire features a comprehensive, flat-fee Press Release service. Generate quality engagement with real-time analytics to improve visibility and expand your influence. 
From Zomedica Corp.
Via AccessWire
Stocks That Hit 52-Week Lows On Thursday
During Thursday, 849 stocks hit new 52-week lows. 
Via Benzinga
Earnings Scheduled For May 10, 2022
Companies Reporting Before The Bell • The Middleby (NASDAQ:MIDD) is expected to report quarterly earnings at $2.10 per share on revenue of $935.99 million. 
Via Benzinga
Stocks That Hit 52-Week Lows On Wednesday
Wednesday's session saw 784 companies set new 52-week lows. 
Via Benzinga
Continue to Steer Clear of MULN Stock
Small-cap, battleground EV play MULN stock could deliver a blow to bears, but for today investors should simply avoid a poor investment. 
Via InvestorPlace
Zomedica to Present at H.C. Wainwright Global Investment Conference
ANN ARBOR, MI / ACCESSWIRE / April 27, 2022 / Zomedica Corp. (NYSE American:ZOM), a veterinary health company offering point-of-care diagnostics and therapeutic products for companion animals,... 
From Zomedica Corp.
Via AccessWire
Zomedica's Announces Designation of Pulsevet System as the Official Shock Wave Therapy of the American Quarter Horse Association
ANN ARBOR, MI / ACCESSWIRE / April 13, 2022 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or the "Company"), a veterinary health company offering diagnostic and therapeutic products for companion... 
From Zomedica Corp.
Via AccessWire
Zomedica Announces Launch of eACTH Assay for Truforma(R) Platform
ANN ARBOR, MI / ACCESSWIRE / April 4, 2022 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or the "Company"), a veterinary health company offering diagnostic and therapeutic products for companion... 
From Zomedica Corp.
Via AccessWire
Zomedica (NYSE American: ZOM) Featured in Coverage of Investor Summit Group’s Q1 Virtual Event
Via Investor Brand Network
Zomedica (NYSE American: ZOM) Featured in Coverage of Investor Summit Group’s Q1 Virtual Event
Via CryptoCurrencyWire
Will the PulseVet Acquisition Continue to Deliver Sales for Zomedica?
ΖΟM stock is a penny stock that is trying to make a turnaround. A positive catalyst is present in the form of sales growth. 
Via InvestorPlace
Zomedica Corporation Reports 2021 Fourth Quarter & Full Year Results
ANN ARBOR, MI / ACCESSWIRE / March 1, 2022 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or the "Company"), a veterinary health company offering diagnostic and therapeutic products for companion... 
From Zomedica Corp.
Via AccessWire
Zomedica Announces Fourth Quarter and 2021 Revenues of $4.1 Million; 73.9% Gross Margin
ANN ARBOR, MI / ACCESSWIRE / February 25, 2022 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or the "Company"), a veterinary health company offering diagnostic and therapeutic products for companion... 
From Zomedica Corp.
Via AccessWire
< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.